Sexually Transmitted Disease Surveillance 2021: Impact of COVID-19 on STDs

Details

• Corporate Authors:
  National Center for HIV, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of STD Prevention.
• Description:
  During 2020, the COVID-19 pandemic led to disruptions in STD-related prevention and care activities, including reduced screening during the initial shelter-in-place orders. STD program resources, including STD case investigations, were also redirected to COVID-19 activities. Because STDs often do not show symptoms, and screening is necessary for timely diagnosis and treatment, changes in access to sexual health care can affect the number of infections diagnosed and reported. The impact of these disruptions likely continued in 2021 and, as a result, STD surveillance data collected during 2020 and 2021 and presented in Sexually Transmitted Disease Surveillance, 2021 should be interpreted cautiously.
• Subjects:
  Chlamydia Infections COVID-19 Gonorrhea Population Surveillance Sexually Transmitted Diseases/epidemiology Syphilis
• Series:
  Sexually Transmitted Disease Surveillance
• Document Type:
  Text
• Genre:
  Webpage
• Collection(s):
  Stephen B. Thacker CDC Library
• Main Document Checksum:
  urn:sha-512:2b82cacd6bec4f1875e98173c4184aace3547be385f1f31ea3bac7e077a70cc06876f70c303c973a391fb07ec6836cf12cbb60233f4153102ca30c75bee12559
• Download URL:
  https://stacks.cdc.gov/view/cdc/127212/cdc_127212_DS1.pdf
• File Type:
  [PDF - 398.80 KB ]